Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means
Trump plans to promote a "Global minimum price" drug reform order, which could reduce U.S. drug prices by up to 80%.
Trump plans to sign an executive order to lower the cost of pharmaceuticals in the USA, ensuring that Americans do not pay more for drugs than the lowest-priced country.
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Trump Says He'll Sign Executive Order to Lower Prescription-drug Prices
Is Gilead Sciences (GILD) Among the Best Stocks to Buy According to Jim Simons' Renaissance Technologies?
Top Analyst Reports for Walt Disney, Gilead Sciences & Eaton
Express News | Gilead Sciences Inc - Stockholders Reject Dei Practices Risk Report Proposal for Contractors - SEC Filing
FDA to Speed up AI Rollout to Accelerate Drug Reviews
Merck Boosts U.S. Investments With $895M Expansion in Kansas Site
How To Put $100 In Your Retirement Fund Each Month With Gilead Sciences Stock
Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Gilead to Invest $11 Billion to Bolster Domestic Manufacturing and Research -- WSJ
Gilead Sciences | 10-Q: Q1 2025 Earnings Report
Express News | Gilead to Invest $32 Billion in U.S. Manufacturing and R&D Through 2030 and Create More Than 3,000 Direct and Indirect Jobs by 2028
Gilead Sciences (NasdaqGS:GILD) Presents Promising Data On Livdelzi And Bulevirtide At EASL 2025
Express News | Gilead Showcases Livdelzi's Efficacy And Tolerability In PBC, With 60% Response Rate Among Patients With Prior Fibrate Or OCA Use, At EASL 2025
Express News | Gilead's Bulevirtide Shows Durability In Chronic HDV, With 90% of Patients on Long-Term Therapy Maintaining Undetectable HDV RNA Off-Treatment
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator
Gilead Sciences Down Nearly 5%, On Track for Largest Percent Decrease Since January 2024 -- Data Talk